NCT07276373 2026-04-03
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Corcept Therapeutics
Phase 1/2 Recruiting
Corcept Therapeutics
Bristol-Myers Squibb
Isala
Hoosier Cancer Research Network
Gustave Roussy, Cancer Campus, Grand Paris
Biond Biologics
The Netherlands Cancer Institute